(19)
(11) EP 4 824 083 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828039.8

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
C07K 14/78(2006.01)
C12N 15/85(2006.01)
C07K 14/725(2006.01)
A61K 40/11(2025.01)
A61K 40/32(2025.01)
A61K 40/31(2025.01)
 C12N 5/0783(2010.01)
C07K 14/47(2006.01)
C12N 15/113(2010.01)
A61K 40/30(2025.01)
A61K 40/42(2025.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/4702; C07K 14/7051; C12N 5/0636; C12N 2310/20; A61K 2239/57; C12N 2510/00; A61K 40/11; A61K 40/32; A61K 40/42; C12N 15/113
(86) International application number:
PCT/EP2024/085747
(87) International publication number:
WO 2025/125363 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 EP 23315449

(71) Applicants:
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • Université d'Aix-Marseille
    13007 Marseille (FR)
  • Centre National de la Recherche Scientifique
    75016 Paris (FR)
  • Carmil
    53940 Le Genest-Saint-Isle (FR)

(72) Inventors:
  • MALISSEN, Bernard
    75016 Paris (FR)
  • MALISSEN, Marie
    75016 Paris (FR)
  • CELIS GUTIERREZ, Javier
    75013 Paris (FR)
  • RONCAGALLI, Romain
    75016 Paris (FR)

(74) Representative: Icosa 
83 avenue Denfert-Rochereau
75014 Paris
75014 Paris (FR)

   


(54) HOST CELLS ENGINEERED TO BYPASS THE CD28 CO-STIMULATION PATHWAY AND USES THEREOF FOR INDUCING DURABLE IMMUNE RESPONSES UNDER NON-INFLAMMATORY CONDITIONS